These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9231346)

  • 1. Pharmacokinetics and kinetic-dynamic modelling of aminophenones as methaemoglobin formers.
    Marino MT; Urquhart MR; Sperry ML; Bredow JV; Brown LD; Lin E; Brewer TG
    J Pharm Pharmacol; 1997 Mar; 49(3):282-7. PubMed ID: 9231346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The induction of methaemoglobin by p-aminophenones.
    Bright JE; Marrs TC
    Toxicol Lett; 1983 Aug; 18(1-2):157-61. PubMed ID: 6623541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The formation of methaemoglobin by 4-aminopropiophenone (PAPP) and 4-(N-hydroxy) aminopropiophenone.
    Marrs TC; Inns RH; Bright JE; Wood SG
    Hum Exp Toxicol; 1991 May; 10(3):183-8. PubMed ID: 1678947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of methaemoglobin production. (2). Kinetics of the cyanide antidote p-aminopropiophenone during oral administration.
    Bright JE; Marrs TC
    Hum Toxicol; 1986 Sep; 5(5):303-7. PubMed ID: 3770767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of methaemoglobin production. (1). Kinetics of methaemoglobinaemia induced by the cyanide antidotes, p-aminopropiophenone, p-hydroxyaminopropiophenone or p-dimethylaminophenol after intravenous administration.
    Marrs TC; Bright JE
    Hum Toxicol; 1986 Sep; 5(5):295-301. PubMed ID: 3770766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect on blood and plasma cyanide levels and on methaemoglobin levels of cyanide administered with and without previous protection using PAPP.
    Marrs TC; Bright JE
    Hum Toxicol; 1987 Mar; 6(2):139-45. PubMed ID: 3557471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of p-aminopropiophenone (PAPP), a cyanide antidote, on cyanide given by intravenous infusion.
    Bright JE; Marrs TC
    Hum Toxicol; 1987 Mar; 6(2):133-7. PubMed ID: 3557470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of methemoglobin formers in protection against the toxic effects of cyanide.
    Scharf BA; Fricke RF; Baskin SI
    Gen Pharmacol; 1992 Jan; 23(1):19-25. PubMed ID: 1592224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of intramuscularly administered cyanide antidotes on methemoglobin formation and survival.
    Vick JA; Von Bredow JD
    J Appl Toxicol; 1996; 16(6):509-16. PubMed ID: 8956097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511).
    Marino MT; Peggins JO; Brown LD; Urquhart MR; Brewer TG
    Drug Metab Dispos; 1994; 22(3):358-66. PubMed ID: 8070311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hematologic consequences and efficacy of p-aminophenones in mice.
    Rockwood GA; Baskin SI; Romano JA; Murrow ML; Preville JA; Lee RB; Sweeney RE
    Environ Toxicol Pharmacol; 1999 Oct; 7(4):237-52. PubMed ID: 21781932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Permeability of 5 methemoglobin formers through red cell membrane].
    Ye L; Huang RH
    Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):560-3. PubMed ID: 2130623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operant leverpressing and wheelrunning were differentially reduced by PAPP (p-aminopropiophenone)-induced methemoglobinemia.
    Bauman RA; Widholm JJ
    Pharmacol Biochem Behav; 2007 Oct; 87(4):444-52. PubMed ID: 17658589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the pharmacokinetics and metabolism of 4-amino-propiophenone (PAPP) in rats, dogs and cynomolgus monkeys.
    Wood SG; Fitzpatrick K; Bright JE; Inns RH; Marrs TC
    Hum Exp Toxicol; 1991 Sep; 10(5):365-74. PubMed ID: 1683551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous modeling of the pharmacokinetics and methemoglobin pharmacodynamics of an 8-aminoquinoline candidate antimalarial (WR 238605).
    Brueckner RP; Fleckenstein L
    Pharm Res; 1991 Dec; 8(12):1505-10. PubMed ID: 1808614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural and physiological assessments of dimethyl trisulfide treatment for acute oral sodium cyanide poisoning.
    Rice NC; Rauscher NA; Wilkins WL; Lippner DS; Rockwood GA; Myers TM
    Basic Clin Pharmacol Toxicol; 2019 Sep; 125(3):289-303. PubMed ID: 30843331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in the production of methaemoglobinaemia by 4-aminopropiophenone.
    Bright JE; Woodman AC; Marrs TC; Wood SG
    Xenobiotica; 1987 Jan; 17(1):79-83. PubMed ID: 3825178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The experimental treatment of cyanide poisoning with a methemoglobin solution].
    Kontuganov NN; Smirnov IV
    Eksp Klin Farmakol; 1992; 55(3):59-61. PubMed ID: 1458169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and methemoglobinemia-inducing properties of analogues of para-aminopropiophenone designed as humane rodenticides.
    Rennison D; Conole D; Tingle MD; Yang J; Eason CT; Brimble MA
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6629-35. PubMed ID: 24210502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactivation of the cyanide antidote 4-aminopropiophenone (4-PAPP) by human and rat hepatic microsomal enzymes: effect of inhibitors.
    Coleman MD; Kuhns MJ
    Environ Toxicol Pharmacol; 1999 Mar; 7(1):75-80. PubMed ID: 21781912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.